Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Spence

Showing results (61-70 of 132) with videos related to

Pageof 14
Sort By:
Clinical Pharmacokinetics|February 1, 1994
Grapefruit juice and drugs. How significant is the interaction?D G Bailey, J M Arnold, J D Spence
Current Hypertension Reports|November 4, 2000
Hypertension in patients presenting with strokeB J Pearson, P M Bath, J D Spence
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Pseudohypertension in the elderlyJ D Spence, W J Sibbald, R D Cape
Neurology|July 1, 1985
Monoamine oxidase inhibitors and Sinemet in Shy-Drager syndromeA Rae-Grant, G B Young, J D Spence
Lancet (London, England)|July 13, 1985
Effects of triamterene and amiloride on urinary sediment in hypertensive patients taking hydrochlorothiazideJ D Spence, D G Wong, R M Lindsay
Canadian Journal of Surgery. Journal Canadien De Chirurgie|November 1, 1983
Doppler flow maps of the carotid artery compared with the findings on angiographyJ D Spence, R K Coates, J A Pexman
Journal of the American Geriatrics Society|April 1, 1981
Diuretics and the institutional elderly: a case against routine potassium prescribingP J Henschke, J D Spence, R D Cape
Stroke|September 1, 1977
Effects of antihypertensive drugs on blood velocity in rhesus monkeysJ D Spence, A B Pesout, K L Melmon
Clinical Pharmacokinetics|February 11, 2000
Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibitionG K Dresser, J D Spence, D G Bailey
American Journal of Nephrology|July 7, 1999
Effect of usual doses of folate supplementation on elevated plasma homocyst(e)ine in hemodialysis patients: no difference between 1 and 5 mg dailyJ D Spence, P Cordy, C Kortas, et al.
Pageof 14

Showing results (61-70 of 132) with videos related to

Sort By:
Pageof 14
Clinical Pharmacokinetics|February 1, 1994
Grapefruit juice and drugs. How significant is the interaction?D G Bailey, J M Arnold, J D Spence
Current Hypertension Reports|November 4, 2000
Hypertension in patients presenting with strokeB J Pearson, P M Bath, J D Spence
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Pseudohypertension in the elderlyJ D Spence, W J Sibbald, R D Cape
Neurology|July 1, 1985
Monoamine oxidase inhibitors and Sinemet in Shy-Drager syndromeA Rae-Grant, G B Young, J D Spence
Lancet (London, England)|July 13, 1985
Effects of triamterene and amiloride on urinary sediment in hypertensive patients taking hydrochlorothiazideJ D Spence, D G Wong, R M Lindsay
Canadian Journal of Surgery. Journal Canadien De Chirurgie|November 1, 1983
Doppler flow maps of the carotid artery compared with the findings on angiographyJ D Spence, R K Coates, J A Pexman
Journal of the American Geriatrics Society|April 1, 1981
Diuretics and the institutional elderly: a case against routine potassium prescribingP J Henschke, J D Spence, R D Cape
Stroke|September 1, 1977
Effects of antihypertensive drugs on blood velocity in rhesus monkeysJ D Spence, A B Pesout, K L Melmon
Clinical Pharmacokinetics|February 11, 2000
Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibitionG K Dresser, J D Spence, D G Bailey
American Journal of Nephrology|July 7, 1999
Effect of usual doses of folate supplementation on elevated plasma homocyst(e)ine in hemodialysis patients: no difference between 1 and 5 mg dailyJ D Spence, P Cordy, C Kortas, et al.
Pageof 14